Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018025 · ClinicalTrials.gov registry record
NDPH Biomarker Study in Children and Adolescents
A clinical trial of New Persistent Daily Headache, sponsored by Duke University.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT06018025 is a study of New Persistent Daily Headache that has completed, run by Duke University. The registered enrollment target is 38 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06018025, a study of New Persistent Daily Headache, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will recruit pediatric patients with NDPH (New Daily Persistent Headache), characterize their headache in a standard manner, and treat the NDPH with standard medications used for treatment of headaches in this population. Response to treatment with CGRP blocking Ab medications will be evaluated. Biomarkers related to headache disorders will be measured before and after treatment.
Conditions Studied
Interventions
- DRUG CGRP antibody
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2025-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06018025
The ClinicalTrials.gov registry entry for NCT06018025 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with New Persistent Daily Headache appearing as the primary indexed condition, and to 1 intervention - of which CGRP antibody is the first listed.
NCT06018025 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06018025 about?
NCT06018025 is a clinical study titled "NDPH Biomarker Study in Children and Adolescents". This study will recruit pediatric patients with NDPH (New Daily Persistent Headache), characterize their headache in a standard manner, and treat the NDPH with standard medications used for treatment of headaches in this population. Response to treatment with CGRP blocking Ab medications will be eva...
What is the current status of trial NCT06018025?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2024-04-15. Estimated completion is 2025-05-29.
What conditions does trial NCT06018025 study?
This clinical trial studies the following conditions: New Persistent Daily Headache.
What interventions are being tested in trial NCT06018025?
The interventions under investigation include: CGRP antibody (DRUG).
Who is sponsoring clinical trial NCT06018025?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06018025 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.